PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNoticescategoryCategories
BuyersSuppliersNoticesCategories
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Shire Pharmaceuticals Ltd
SP

Shire Pharmaceuticals Ltd

UK public-sector supplier
SME

Takeda Pharmaceuticals is a global biopharmaceutical company focused on research and development of innovative medicines. They aim to improve patient outcomes through their products and corporate responsibility initiatives.

takeda.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£170.5m
Live
3
Buyers
3
12m
—
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities4
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts3 / 10
  • Top buyers3
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Shire Pharmaceuticals LtdUpdated 20 Jul 2026

At a glance · for buyers and watchdogs

Shire Pharmaceuticals Ltd has won £170.5m across 3 public-sector buyers, with 3 live contracts.

Why: top buyer NHS England at 100% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
No CH recordCompany status
3 of 10Live contracts
100%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 2
Our ProductsTakeda offers a range of pharmaceutical products across various therapeutic areas. ↗ManufacturingTakeda has a robust manufacturing process to ensure the quality of its pharmaceutical products. ↗
Frameworks & DPS · 4 from notices
  • NHS National Framework Agreement for the supply of products for the treatment of Haemophilia ANHS England · £37.2m
  • NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary AngioedemaNHS England · £24.0m
  • NHS National Framework Agreement for the Supply of LanadelumabNHS England · £4.8m
  • NHS National Framework agreement for the supply of Homecare Delivery Service - Products for the treatment of bleeding disorders in England, Wales and Northern IrelandNHS England · £1.6m

Extracted automatically from takeda.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies · 1

Delivery stories from the supplier’s website. Clients are not yet cross-checked against award records.

◐ From supplier website
Setting a new testing standard in the battle against polioThis case study discusses Takeda's efforts in establishing new testing standards to combat polio. ↗

Extracted automatically from takeda.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 3 live · 7 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Human Normal Immunoglobulin and Anti-D Immunoglobulin
NHS England3365152001 Jul 2021£64.3m1.5 yrsClosed
Recombinant Von Willebrand Factor
NHS England3360000001 Feb 2021£250k5 moClosed
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A
NHS England3360000001 Jul 2020£37.2m2 yrsClosed
NHS National Framework Agreement for the Supply of Lanadelumab
NHS England3360000001 Jan 2020£4.8m12 moClosed
NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B
NHS England3314153001 Mar 2019£38.4m2 yrsClosed
NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
NHS England3360000001 Jul 2018£24.0m12 moClosed
NHS National Framework agreement for the supply of Homecare Delivery Service - Products for the treatment of bleeding disorders in England, Wales and Northern Ireland
NHS England8514121001 Jul 2018£1.6m2 yrsClosed
NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor
The NHS Commissioning Board (operating under the name of NHS England)33141530———Live
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin
The NHS Commissioning Board (operating under the name of NHS England)33651520———Live
Medicinal Products and Pharma Funded Homecare Services
BELFAST HEALTH AND SOCIAL CARE TRUST85141210———Live
Total live value — · mean award £17.1m

Top buyers · 3 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
7 contracts
100%
since 2018
2
The NHS Commissioning Board (operating under the name of NHS England)
2 contracts
0%
3
BELFAST HEALTH AND SOCIAL CARE TRUST
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire7 contracts
100%
North West2 contracts
0%
Northern Ireland1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Shire Pharmaceuticals Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m20
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m13
TA
Thornton and Ross Ltd
Yes£72.5m11
AC
ACCORD-UK LTD
Yes£71.2m21
SP
Shire Pharmaceuticals Ltd
Yes——
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
No Companies House record linked — automated risk checks unavailable.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
No Companies House record linked — statutory compliance checks unavailable.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Registered details, directors and PSC.

✓ Live sync
🏛

No Companies House record linked

A Companies House number is on file but the record has not been synced yet.

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
—
02031674 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.